Inovio Pharmaceuticals INO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.74 | -421.44 | 0.31 | -17,477 | 4 | |
| 2025Q3 | 2.34 | 47.02 | -1.00 | -21,210 | -45 | |
| 2025Q2 | 2.04 | 92.13 | -0.61 | -23,085 | -24 | |
| 2025Q1 | 1.63 | 122.02 | -0.51 | -25,051 | -20 | |
| 2024Q4 | 1.83 | 109.41 | -0.60 | -20,370 | -19 | |
| 2024Q3 | 5.78 | 101.96 | -0.87 | -27,347 | -25 | |
| 2024Q2 | 8.08 | 104.12 | -1.17 | -33,197 | -32 | |
| 2024Q1 | 13.88 | 102.67 | -1.31 | -31,485 | -30 | |
| 2023Q4 | 6.12 | 103.62 | -1.08 | -27,394 | -25 | |
| 2023Q3 | 4.67 | 105.78 | -1.51 | -35,553 | -34 | |
| 2023Q2 | 5.36 | 102.04 | -1.61 | -37,041 | -36 | |
| 2023Q1 | 9.84 | 99.50 | -1.89 | -43,952 | -41 | |
| 2022Q4 | 18.72 | 98.46 | -2.55 | -55,946 | -54 | |
| 2022Q3 | 20.70 | 101.20 | -1.56 | -35,757 | -38 | |
| 2022Q2 | 20.76 | 100.83 | -5.64 | -104,137 | -108 | |
| 2022Q1 | 43.08 | 100.72 | -4.32 | -71,733 | -79 | |
| 2021Q4 | 59.88 | 101.03 | -6.05 | -105,508 | -107 | |
| 2021Q3 | 85.92 | 101.25 | -3.48 | -59,953 | -60 | |
| 2021Q2 | 111.24 | 101.36 | -4.68 | -83,202 | -82 | |
| 2021Q1 | 111.36 | 101.50 | -3.24 | -52,554 | -54 |